Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

被引：8
作者：
Kreyenberg, H. [1 ]
Eckert, C. [2 ]
Yarkin, Y. [3 ]
Reising, M. [1 ]
Willasch, A. [1 ]
Handgretinger, R. [3 ]
Kremens, B. [4 ]
von Stackelberg, A. [2 ]
Henze, G. [2 ]
Klingebiel, T. [1 ]
Bader, P. [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Paediat Oncol Haematol & Haemostaseol, Childrens Hosp, Frankfurt, Germany
[2] Humboldt Univ, Dept Paediat Oncol Haematol, Charite Hosp, Berlin, Germany
[3] Univ Tubingen, Dept Haematol Oncol, Childrens Univ Hosp, Tubingen, Germany
[4] Univ Essen Gesamthsch, Dept Pediat Haematol Oncol & Endocrinol, Essen, Germany
来源：
LEUKEMIA | 2009年 / 23卷 / 07期
关键词：
CONCERTED ACTION; RELAPSE; PROTOCOLS; CHILDREN; PRIMERS;
D O I：
10.1038/leu.2009.72
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1355 / 1358
页数：5
相关论文
共 50 条
  • [41] Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006
    Thorn, Ingrid
    Forestier, Erik
    Thuresson, Britt
    Wasslavik, Carina
    Malec, Maria
    Li, Aihong
    Lindstrom-Eriksson, Elenor
    Botling, Johan
    Barbany, Gisela
    Jacobsson, Stefan
    Olofsson, Tor
    Porwit, Anna
    Sundstrom, Christer
    Rosenquist, Richard
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (02) : 117 - 127
  • [42] Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia
    Wang, Huanping
    Zhou, Yile
    Huang, Xin
    Zhang, Yi
    Qian, Jiejing
    Li, Jianhu
    Li, Chenying
    Li, Xueying
    Lou, Yinjun
    Zhu, Qiaoyun
    Huang, Yujie
    Meng, Haitao
    Yu, Wenjuan
    Tong, Hongyan
    Jin, Jie
    Zhu, Hong-Hu
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1096 - 1104
  • [43] Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia
    Zhao, Yan-Li
    Liu, De-Yan
    Sun, Rui-Juan
    Zhang, Jian-Ping
    Zhou, Jia-Rui
    Wei, Zhi-Jie
    Xiong, Min
    Cao, Xing-Yu
    Lu, Yue
    Yang, Jun-fang
    Zhang, Xian
    Lu, Dao-Pei
    Lu, Peihua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Development of a gastric carcinoid tumor following allogeneic hematopoietic stem cell transplantation for early T-cell precursor acute lymphoblastic leukemia
    Chang, Tsung-Yen
    Lai, Jin-Yao
    Wang, Chao-Jan
    Chen, Shih-Yen
    Jaing, Tang-Her
    Hsueh, Chuen
    Shih, Lee-Yung
    Chen, Shih-Hsiang
    PEDIATRIC TRANSPLANTATION, 2017, 21 (04)
  • [45] The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission
    Zhao, Xiao-Su
    Qin, Ya-Zhen
    Liu, Yan-Rong
    Chang, Ying-Jun
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Huang, Xiao-Jun
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1135 - 1143
  • [46] Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
    Subhash, Vinod Vijay
    Huang, Libby
    Kamili, Alvin
    Wong, Marie
    Chen, Dan
    Venn, Nicola C.
    Atkinson, Caroline
    Mayoh, Chelsea
    Venkat, Pooja
    Tyrrell, Vanessa
    Marshall, Glenn M.
    Cowley, Mark J.
    Ekert, Paul G.
    Norris, Murray D.
    Haber, Michelle
    Henderson, Michelle J.
    Sutton, Rosemary
    Fletcher, Jamie, I
    Trahair, Toby N.
    BRITISH JOURNAL OF CANCER, 2022, 126 (03) : 482 - 491
  • [47] Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
    Mo, Xiao-Dong
    Qin, Ya-Zhen
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Liu, Kai-Yan
    Huang, Xiao-Jun
    ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1233 - 1240
  • [48] Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
    Lankester, A. C.
    Bierings, M. B.
    van Wering, E. R.
    Wijkhuijs, A. J. M.
    de Weger, R. A.
    Wijnen, J. T.
    Vossen, J. M.
    Versluys, B.
    Egeler, R. M.
    van Tol, M. J. D.
    Putter, H.
    Revesz, T.
    van Dongen, J. J. M.
    van der Velden, V. H. J.
    Schilham, M. W.
    LEUKEMIA, 2010, 24 (08) : 1462 - 1469
  • [49] Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia
    Elorza, Izaskun
    Palacio, Carlos
    Luis Dapena, Jose
    Gallur, Laura
    Sanchez de Toledo, Jose
    Diaz de Heredia, Cristina
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06): : 936 - 941
  • [50] Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial
    Bader, Peter
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Eckert, Cornelia
    Salzmann-Manrique, Emilia
    Meisel, Roland
    Poetschger, Ulrike
    Stachel, Daniel
    Schrappe, Martin
    Alten, Julia
    Schrauder, Andre
    Schulz, Ansgar
    Lang, Peter
    Mueller, Ingo
    Albert, Michael H.
    Willasch, Andre M.
    Klingebiel, Thomas E.
    Peters, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1275 - +
12345